Natixis Advisors
NARI

Natixis Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Natixis Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,002
Closed -$511K – 1696
2024
Q4 		$511K Buy
+10,002
New +$492K ﹤0.01% 1464
2022
Q4 		– Sell
-10,646
Closed -$773K – 1525
2022
Q3 		$773K Buy
+10,646
New +$793K ﹤0.01% 1172

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Natixis Advisors's NARI Position: Q1 2025 in Review

Natixis Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 10,002 shares — an estimated $511K sold.

Natixis Advisors first reported a position in NARI in Q3 2022 and held it in 2 quarters. The position peaked at $773K in Q3 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Natixis Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Natixis Advisors sold 10,002 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $511K.
  • Natixis Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Natixis Advisors's Inari Medical, Inc. Common Stock position peaked at $773K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Natixis Advisors's 13F filing for Q1 2025, filed 8 May 2025.